Chao Zhang mostly deals with Cell biology, Nanotechnology, Biochemistry, Kinase and Chemical engineering. His studies in Cell biology integrate themes in fields like Cyclin-dependent kinase 1, Cyclin-dependent kinase and Cell growth. His Nanotechnology research incorporates themes from Oxide and Electrode.
His Electrode study frequently draws connections between adjacent fields such as Optoelectronics. His Biochemistry study focuses mostly on Protein kinase A and Cyclin-dependent kinase 2. His studies deal with areas such as Molecular biology, Cancer research and Phosphorylation as well as Kinase.
His scientific interests lie mostly in Artificial intelligence, Composite material, Nanotechnology, Chemical engineering and Cell biology. His Artificial intelligence research includes elements of Machine learning, Computer vision and Pattern recognition. Composite material is a component of his Composite number, Coating and Microstructure studies.
His specific area of interest is Nanotechnology, where Chao Zhang studies Graphene.
His primary scientific interests are in Composite material, Artificial intelligence, Chemical engineering, Cancer research and Optoelectronics. Composite material is often connected to Finite element method in his work. His Artificial intelligence research includes themes of Natural language processing, Machine learning, Code and Pattern recognition.
His primary areas of study are Composite material, Artificial intelligence, Chemical engineering, Optoelectronics and Nanotechnology. His research ties Finite element method and Composite material together. As a part of the same scientific family, Chao Zhang mostly works in the field of Artificial intelligence, focusing on Natural language processing and, on occasion, Benchmark.
The concepts of his Chemical engineering study are interwoven with issues in Ion, Carbon and Oxygen evolution, Electrochemistry. His biological study deals with issues like Raman scattering, which deal with fields such as Plasmon. His Nanotechnology study frequently intersects with other fields, such as Self-healing hydrogels.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma
Gideon Bollag;Peter Hirth;James Tsai;Jiazhong Zhang.
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos;Chao Zhang;Gideon Bollag;Kevan M. Shokat.
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
Jonathan H. Lin;Han Li;Douglas Yasumura;Hannah R. Cohen.
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai;John T. Lee;Weiru Wang;Jiazhong Zhang.
Proceedings of the National Academy of Sciences of the United States of America (2008)
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
Fei Su;Amaya Viros;Carla Milagre;Kerstin Trunzer.
The New England Journal of Medicine (2012)
Lanthanide Nanoparticles: From Design toward Bioimaging and Therapy
Hailiang Dong;Shuo-Ren Du;Xiao-Yu Zheng;Guang-Ming Lyu.
Chemical Reviews (2015)
The unfolded protein response signals through high-order assembly of Ire1.
Alexei V. Korennykh;Pascal F. Egea;Andrei A. Korostelev;Janet Finer-Moore.
Vemurafenib: the first drug approved for BRAF -mutant cancer
Gideon Bollag;James Tsai;Jiazhong Zhang;Chao Zhang.
Nature Reviews Drug Discovery (2012)
Structural bioinformatics-based design of selective, irreversible kinase inhibitors.
Michael S. Cohen;Chao Zhang;Kevan M. Shokat;Jack Taunton.
Rapid self-healing hydrogels.
Ameya Phadke;Chao Zhang;Bedri Arman;Cheng-Chih Hsu.
Proceedings of the National Academy of Sciences of the United States of America (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: